Farmaceutica REMEDIA S.A. (BVB:RMAH)

Farmaceutica REMEDIA Balance Sheet

Financials in millions RON. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	38.52	57.94	47.66	34.5	18.08	24.22
Cash & Short-Term Investments	38.52	57.94	47.66	34.5	18.08	24.22
Cash Growth	251.16%	21.58%	38.14%	90.77%	-25.33%	-29.50%
Accounts Receivable	196.54	205.04	216.95	184.26	173.7	137.63
Other Receivables	6.88	4.91	5.6	5.29	2.8	3.78
Receivables	203.42	209.94	222.55	189.56	176.5	141.41
Inventory	50.9	63.37	57.21	44.33	46.26	40.6
Other Current Assets	0	0.04	0.04	0.04	0.04	0
Total Current Assets	292.85	331.3	327.45	268.43	240.89	206.23
Property, Plant & Equipment	49.56	48.44	45.14	44.77	41.81	41.43
Long-Term Investments	0.5	0.3	0.01	0.03	0.59	0.3
Other Intangible Assets	1.24	1.45	1.1	1.18	0.8	0.77
Other Long-Term Assets	1.17	1.7	1.34	1.35	2.11	2.35
Total Assets	345.32	383.19	375.04	315.76	286.2	251.07

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	254.07	291.38	290.77	235.2	209.83	175.9
Accrued Expenses	-	1.98	1.37	1.28	1.59	2.15
Current Portion of Leases	0.16	0.33	0.35	0.93	1.2	1.34
Current Income Taxes Payable	0.83	2.37	1.89	0.33	0.16	-
Other Current Liabilities	11.29	2.04	1.51	1.71	1.82	0.97
Total Current Liabilities	266.6	298.36	295.9	239.45	214.6	180.3
Long-Term Leases	0.42	0.42	0.53	1.2	-	-
Long-Term Deferred Tax Liabilities	4.8	4.8	4.66	4.25	3.18	2.54
Other Long-Term Liabilities	-	0	-	-	-	-0
Total Liabilities	271.82	303.58	301.09	244.9	217.77	182.85

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	9.55	9.55	9.86	9.86	9.86	9.86
Additional Paid-In Capital	0.76	0.76	0.76	0.76	0.76	0.76
Retained Earnings	19.38	28.27	25.02	23.67	20.1	15.79
Treasury Stock	-1.32	-1.32	-0.48	-2.26	-0.11	-0.11
Comprehensive Income & Other	45.13	42.35	38.79	38.84	37.83	41.93
Shareholders' Equity	73.5	79.61	73.94	70.86	68.43	68.22
Total Liabilities & Equity	345.32	383.19	375.04	315.76	286.2	251.07

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	0.58	0.75	0.88	2.13	1.2	1.34
Net Cash (Debt)	37.94	57.19	46.77	32.37	16.88	22.88
Net Cash Growth	246.86%	22.27%	44.52%	91.69%	-26.20%	-31.67%
Net Cash Per Share	0.40	0.60	0.49	0.34	0.18	0.24
Filing Date Shares Outstanding	93.7	93.7	94.66	92.32	95.18	95.18
Total Common Shares Outstanding	93.7	93.7	94.66	92.32	95.18	95.18
Working Capital	26.25	32.94	31.56	28.98	26.3	25.93
Book Value Per Share	0.78	0.85	0.78	0.77	0.72	0.72
Tangible Book Value	72.26	78.16	72.84	69.68	67.64	67.46
Tangible Book Value Per Share	0.77	0.83	0.77	0.75	0.71	0.71
Land	-	6.86	6.03	5.85	5.53	5.41
Buildings	-	19.74	18.97	19.24	16.08	14.42
Machinery	-	8.97	6.9	6.77	8.83	6.39

Data Source: S&P Global Market Intelligence Last updated: Aug 26, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 10, 2026

Data Sources Report a data error